Literature DB >> 10465422

Three-dimensional quantitative structure activity relationships (3-D-QSAR) of antihyperglycemic agents.

S S Kulkarni1, L K Gediya, V M Kulkarni.   

Abstract

A three-dimensional quantitative structure activity relationship study (3-D-QSAR) was performed on a set of thiazolidinedione antihyperglycemic agents using the comparative molecular field analysis (CoMFA) method. The CoMFA models were derived from a training set of 53 compounds. Fifteen compounds, which were not used in model generation were used to validate the CoMFA models. All the compounds were superimposed to the template structure by atom-based and shape-based strategies. The SYBYL QSAR rigid body field fit was also used for aligning the ligands. A total of twelve different alignments were generated. The resulting models exhibited a good cross-validated r2cv values (0.624-0.764) and the conventional r2 values (0.689-0.921). A more robust cross-validation test using cross-validation by 2 groups (leave half out method) was performed 100 times to ascertain the predictiveness of the CoMFA models. The mean of r2cv values from 100 runs ranged from 0.611-0.690. Few models exhibited good external predictivity. These models were then used to define a hypothetical receptor model for antihyperglycemic agents.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10465422     DOI: 10.1016/s0968-0896(99)00063-2

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  5 in total

1.  Development of quantitative structure-binding affinity relationship models based on novel geometrical chemical descriptors of the protein-ligand interfaces.

Authors:  Shuxing Zhang; Alexander Golbraikh; Alexander Tropsha
Journal:  J Med Chem       Date:  2006-05-04       Impact factor: 7.446

2.  Rational Design, Synthesis, and In Vitro Neuroprotective Evaluation of Novel Glitazones for PGC-1α Activation via PPAR-γ: a New Therapeutic Strategy for Neurodegenerative Disorders.

Authors:  Antony Justin; Subhankar Mandal; P Prabitha; S Dhivya; S Yuvaraj; Pradeep Kabadi; Satheesh John Sekhar; C H Sandhya; Ashish D Wadhwani; Selvaraj Divakar; Jeyabalan Jeyaram Bharathi; Priya Durai; B R Prashantha Kumar
Journal:  Neurotox Res       Date:  2019-11-28       Impact factor: 3.911

3.  3D QSAR studies on peroxisome proliferator-activated receptor gamma agonists using CoMFA and CoMSIA.

Authors:  Chenzhong Liao; Aihua Xie; Jiaju Zhou; Leming Shi; Zhibin Li; Xian-Ping Lu
Journal:  J Mol Model       Date:  2004-03-12       Impact factor: 1.810

4.  Novel glitazones as PPARγ agonists: molecular design, synthesis, glucose uptake activity and 3D QSAR studies.

Authors:  Subhankar P Mandal; Aakriti Garg; P Prabitha; Ashish D Wadhwani; Laxmi Adhikary; B R Prashantha Kumar
Journal:  Chem Cent J       Date:  2018-12-19       Impact factor: 4.215

5.  Combined 3D-QSAR modeling and molecular docking study on multi-acting quinazoline derivatives as HER2 kinase inhibitors.

Authors:  Sako Mirzaie; Majid Monajjemi; Mohammad Saeed Hakhamaneshi; Fardin Fathi; Mostafa Jamalan
Journal:  EXCLI J       Date:  2013-02-22       Impact factor: 4.068

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.